Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild‐moderate fibrosis: Results from a real‐world cohort. - Puigvehí, Marc; De Cuenca, Beatriz; Viu, Ana; Diago, Moisés; Turnes, Juan; Gea, Francisco; Pascasio, Juan M.; Lens, Sabela; Cabezas, Joaquín; Badia, Ester; Olveira, Antonio; Morillas, Rosa M.; et al. (Liver International, 2019)